Zimmer Biomet Holdings, Inc. (ZBH)
NYSE: ZBH · Real-Time Price · USD
93.19
+0.75 (0.81%)
Sep 11, 2026, 3:19 PM EDT - Market open
Zimmer Biomet Holdings Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 17,775 | 17,823 | 21,025 | 25,433 | 26,756 | 26,540 | |
Market Cap Growth | -14.31% | -15.23% | -17.33% | -4.95% | 0.81% | -16.91% |
Enterprise Value | 24,912 | 24,763 | 27,103 | 30,846 | 32,091 | 33,133 |
Last Close Price | 92.44 | 89.44 | 104.04 | 118.84 | 123.55 | 118.44 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 22.64 | 25.28 | 23.26 | 24.84 | 115.63 | 66.08 |
Forward PE | 10.63 | 10.72 | 12.52 | 15.47 | 18.63 | 16.40 |
PS Ratio | 2.07 | 2.17 | 2.74 | 3.44 | 3.86 | 3.89 |
PB Ratio | 1.40 | 1.40 | 1.69 | 2.04 | 2.23 | 2.10 |
P/FCF Ratio | 14.69 | 15.21 | 19.92 | 25.98 | 31.91 | 24.53 |
P/OCF Ratio | 10.11 | 10.50 | 14.02 | 16.08 | 20.83 | 17.70 |
PEG Ratio | 1.86 | 1.85 | 1.51 | 1.90 | 2.80 | 1.34 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.91 | 3.01 | 3.53 | 4.17 | 4.62 | 4.85 |
EV/EBITDA Ratio | 9.81 | 9.92 | 10.46 | 12.55 | 14.50 | 15.34 |
EV/EBIT Ratio | 17.48 | 17.67 | 17.00 | 20.49 | 24.95 | 27.11 |
EV/FCF Ratio | 20.63 | 21.13 | 25.68 | 31.52 | 38.27 | 30.62 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.60 | 0.62 | 0.53 | 0.50 | 0.51 | 0.58 |
Debt / EBITDA Ratio | 2.94 | 3.08 | 2.49 | 2.47 | 2.70 | 3.28 |
Debt / FCF Ratio | 6.33 | 6.72 | 6.27 | 6.34 | 7.32 | 6.76 |
Net Debt / Equity Ratio | 0.56 | 0.57 | 0.49 | 0.46 | 0.48 | 0.55 |
Net Debt / EBITDA Ratio | 2.83 | 2.91 | 2.35 | 2.36 | 2.60 | 3.20 |
Net Debt / FCF Ratio | 5.95 | 6.19 | 5.77 | 5.92 | 6.87 | 6.40 |
Asset Turnover | 0.37 | 0.37 | 0.36 | 0.35 | 0.31 | 0.28 |
Inventory Turnover | 1.10 | 1.10 | 0.94 | 0.92 | 0.94 | 0.85 |
Quick Ratio | 0.74 | 0.90 | 0.82 | 0.65 | 0.75 | 0.48 |
Current Ratio | 1.69 | 1.98 | 1.91 | 1.61 | 1.88 | 1.41 |
Return on Equity (ROE) | 6.41% | 5.60% | 7.25% | 8.36% | 2.36% | 3.58% |
Return on Assets (ROA) | 3.88% | 3.94% | 4.65% | 4.42% | 3.61% | 3.19% |
Return on Invested Capital (ROIC) | 6.19% | 6.17% | 7.56% | 8.02% | 4.97% | 5.53% |
Return on Capital Employed (ROCE) | 7.20% | 6.80% | 8.40% | 8.10% | 6.90% | 6.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.58% | 3.96% | 4.30% | 4.03% | 0.86% | 1.51% |
FCF Yield | 6.81% | 6.58% | 5.02% | 3.85% | 3.13% | 4.08% |
Dividend Yield | 1.03% | 1.07% | 0.92% | 0.81% | 0.78% | 0.81% |
Payout Ratio | 23.32% | 26.99% | 21.69% | 19.62% | 86.95% | 49.83% |
Buyback Yield / Dilution | 1.95% | 2.55% | 2.77% | 0.29% | 0.05% | -1.64% |
Total Shareholder Return | 2.99% | 3.62% | 3.69% | 1.09% | 0.83% | -0.83% |